CIK 0001527753 · Services-Medical Laboratories (SIC 8071) · Nasdaq · incorporated in DE · fiscal year ends 12/31
| FY2025 | FY2024 | FY2023 | |
|---|---|---|---|
| Revenue (USD) | 69.6 M | 73.5 M | 65.0 M |
| Net income (USD) | -81.3 M | -108.3 M | -113.3 M |
| Diluted EPS (USD/shares) | -0.91 | -2.25 | -2.48 |
| Filed | Form | Description | Period |
|---|---|---|---|
| 2026-10-21 | DEFM14A | DEFM14A | |
| 2026-10-21 | 425 | 425 | |
| 2026-10-20 | 425 | 425 | |
| 2026-10-20 | SC 13E3/A | SC 13E3/A | |
| 2026-10-06 | 425 | 425 | |
| 2026-10-06 | 8-K | 8-K items 8.01 | 2026-10-02 |
| 2026-10-02 | SC 13E3/A | SC 13E3/A | |
| 2026-10-02 | CT ORDER | CT ORDER items 20261002,20261002 | |
| 2026-09-22 | 4 | 4 | 2026-09-18 |
| 2026-09-22 | 4 | 4 | 2026-09-18 |
| 2026-09-22 | 4 | 4 | 2026-09-18 |
| 2026-09-22 | 4 | 4 | 2026-09-18 |
| 2026-09-15 | 425 | 425 | |
| 2026-08-31 | SC 13E3 | SC 13E3 | |
| 2026-08-20 | 8-K | 8-K items 8.01 | 2026-08-20 |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-14 | SCHEDULE 13G/A | SCHEDULE 13G/A | |
| 2026-08-04 | 10-Q | 10-Q | 2026-06-30 |
| 2026-08-04 | 8-K | 8-K items 2.02,9.01 | 2026-08-04 |
| 2026-07-29 | SCHEDULE 13G | SCHEDULE 13G | |
| 2026-07-21 | SCHEDULE 13D/A | SCHEDULE 13D/A | |
| 2026-07-20 | 425 | 425 | |
| 2026-07-20 | 8-K | 8-K items 1.01,9.01 | 2026-07-20 |
| 2026-07-20 | 425 | 425 | |
| 2026-07-20 | 425 | 425 |
Forms on file (last 1,000): 4 259, 8-K 80, 3 24, 10-Q 22, SC 13G/A 16, S-8 11, 144 10, 425 10. Source: SEC EDGAR, as filed; this page is public data and not investment advice.
GET https://store.agentexchange.work/gw/filings/company?ticker=PSNL (0.002 USD), /gw/filings/filings?ticker=PSNL&form=8-K, /gw/filings/facts?ticker=PSNL&concept=Revenues, full-text /gw/filings/search?q=.... Pay per call in USDC (x402) or with a 19 USD card key for 1,000 calls. Catalogue · llms.txtUpdated from EDGAR within 30 minutes of a filing. Agent Exchange